GNC Publishes Peer-Reviewed Journal Article on Dietary Supplement Considerations for GLP-1 Receptor Agonist Treatment

Strategic Insights -

As the use of GLP-1 medications such as Ozempic and Wegovy for weight loss continues to grow, a new peer-reviewed journal article published by GNC addresses a critical knowledge gap: how dietary supplements can complement GLP-1 therapy to support muscle health, nutrition, and overall wellness. The article, "Dietary Supplement Considerations During Glucagon-like Peptide-1 Receptor Agonist Treatment: A Narrative Review," provides evidence-based data and practical guidance on supplement use, dosing protocols, and integration into clinical care.

Key Takeaways:

  • Multivitamins and Vitamin D can help address common nutrient gaps and improve overall nutrient status.
  • Omega-3s support muscle quality and heart health.
  • Protein, Creatine, and HMB can help preserve lean body mass and strength during weight loss.
  • Antioxidants and anti-inflammatory nutrients, such as curcumin, polyphenols, and CoQ10, can support reducing oxidative stress and the body's natural inflammatory response.
  • Fiber and Probiotics can improve bowel regularity and mitigate gastrointestinal side effects.
  • Thermogenics, such as caffeine and green tea, may increase energy expenditure.
  • GNC's scientific leadership in dietary supplements is committed to delivering evidence-based solutions for individuals using GLP-1 therapies.
  • The publication highlights the need for practical guidance on supplement use and dosing protocols, which can be applied from prior weight loss science.
  • GNC's research team is working to assess nutritional habits, body composition, and health outcomes before and during GLP-1 treatment.

Statistics:

  • Over 96% of GNC branded products are manufactured in the United States using globally sourced ingredients.
  • GNC delivers science-based products and solutions designed to help consumers Live Well.
  • GNC's diversified, multi-channel business model has worldwide reach and a well-recognized, trusted brand.
  • The article highlights the growing use of GLP-1 medications, such as Ozempic and Wegovy, for weight loss.

Sources:

  • GNC
  • "Dietary Supplement Considerations During Glucagon-like Peptide-1 Receptor Agonist Treatment: A Narrative Review" (peer-reviewed journal article)
  • GNC press release, "GNC Publishes Peer-Reviewed Journal Article on Dietary Supplement Considerations for GLP-1 Receptor Agonist Treatment" (Oct. 30, 2025)